Pilot Clinical Trial of the Use of Alpha-tocopherol for the Prevention of Hepatocellular Carcinoma in Patients with Liver Cirrhosis

International Journal for Vitamin and Nutrition Research

Volumn 73, Issue 6, 2003, Pages 411-415

  Takagi, Hitoshi ^a   Kakizaki, Satoru ^a   Sohara, Naondo ^a   Sato, Ken ^a   Gengo, ^a   Tsukioka, ^a   Tago, Youko ^a   Konaka, Kazuko ^a   Kabeya, Kenshi ^a   Kaneko, Mieko ^a   Takayama, Hisashi ^a   Hashimoto, Yoshiaki ^a   Yamada, Toshihiko ^a   Takahashi, Hitomi ^a   Shimojo, Hiroshi ^a   Nagamine, Takeaki ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Alpha tocopherol; Chemoprevention; HCV; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ALPHA TOCOPHEROL; CHOLESTEROL;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CIRRHOSIS; MALE; MORTALITY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

HEPATITIS C VIRUS;

EID: 0346256873     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.73.6.411     Document Type: Article

References (22)

1. Hong, W. K. and Sporn, M. B. (1997) Recent advances in chemoprevention of cancer. Science 278, 1073-1077.
2. Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K. and Otani, S. (1995) Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346, 1051-1055.
3. Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S. R., Monna, T., Kobayashi, K. and Tango, T. (1995) Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 76, 743-749.
4. Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., Nakamura, T. and Kojima, T. (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med. 334, 1561-1567.
5. Yu, S. Y., Zhu, Y. J., Li, W. G., Huang, Q. S., Huang, C. Z., Zhang, Q. N. and Hou, C. (1991) A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol. Trace Elem. Res. 29, 289-294.
6. Kakizaki, S., Takagi, H., Fukusato, T., Toyoda, M., Horiguchi-Nsato, K., Takayama, H., Nagamine, T. and Mori, M. (2001) Effect of alpha-tocopherol on hepatocarcinogenesis in transforming growth factor-alpha (TGF-alpha) transgenic mice treated with diethylnitrosamine. Int. J. Vit. Nutr. Res. 71, 261-267.
7. Moore, S. R., Hill, K. A., Heinmoller, P. W., Halangoda, A., Kunishige, M, Buettner, V. L., Grabara, K. S. and Sommer, S. S. (1999) Spontaneous mutation frequency and pattern in Big Blue mice fed a vitamin E-supplemented diet. Environ. Mol. Mutagen. 34, 195-200.
8. Cubby Hendrich S., Duitsman, P., Krueger, S. K., Jackson, A. and Myeres, R. K. (1991) Effects of alpha-tocopherol, phenobarbital, and butylated hydroxyanisole during promotion of diethylnitrosamine-initiated rat hepatocarcinogenesis. Nutr. Cancer 15, 53-62.
9. Kolaja, K. L. and Klaunig, J. E. (1995) Vitamin E modulation of hepatic focal lesion growth in mice. Toxicol. Appl. Pharmacol. 143, 380-387.
10. Tsuda, H., Uehara, N., Iwahori, Y., Asamoto, M., Iigo, M., Nagao, M., Matsumoto, K., Ito, M. and Hirono, I. (1994) Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazole[4,5-f] quinoline in the rat. Jpn. J. Cancer Res. 85, 1214-1219.
11. Meydani, M. (1995) Vitamin E. Lancet 345, 170-175.
12. Yoshikawa, T., Takemura, S. and Kondo, M. (1982) Alpha-tocopherol level in liver diseases. Acta Vitaminol. Enzymol. 4, 311-318.
13. Leo, M. A., Rosman, A. S. and Lieber, C. S. (1993) Differential depletion of carotenoids and tocopherol in liver disease. Hepatology 17, 977-986.
14. Kappus, H. and Diplock, A. T. (1992) Tolerance and safety of vitamin E: a toxicological position report. Free Radic. Biol. Med. 13, 55-74.
15. Rocchi, E., Seium, Y., Camellini, L., Casallgrand, G., Borghi, A. and D'Alimonte Cioni, G. (1997) Hepatic tocopherol content in primary hepatocellular carcinoma and liver metastasis. Hepatology 26, 67-72.
16. Ideo, G., Bellobuono, A., Tempini, S., Mondazzi, L., Airoldi, A., Benetti, G., Bissoli, F., Cestari, C., Colombo, E., Del Poggio, P., Fracassetti, O., Lazzaroni, S., Marelli, A., Paris, B., Prada, A., Rainer, E. and Roffi, L. (1999) Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomised, multicenter study. Eur. J. Gastroenterol. Hepatol. 11, 1203-1207.
17. Andreone, P., Fiorino, S., Cursaro, C., Gramenzi, A., Margotti, M., Di Giammarino, L., Biselli, M., Miniero, R., Gasbarrini, G. and Bernardi, M. (2001) Vitamin E as treatment for chronic hepatitis B: results of a randomised controlled pilot trial. Antiviral Res. 49, 75-81.
18. Dowd, P. and Zheng, Z. B. (1995) On the mechanism of the anticlotting action of vitamin E quinone. Proc. Natl. Acad. Sci. USA 92, 8171-8175.
19. Neuzil, J., Weber, T., Terman, A., Weber, C. and Brunk, U. T. (2001) Vitamin E analogues as inducers of apoptosis: Implications for their potential antineoplastic role. Redox Rep. 63, 143-151.
20. Uehara, H., Sato, N. and Mori, M. (1994) Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma. Hepatology 20, 326-330.
21. Yu, W., Israel, K., Yin Liao, Q., Aldaz, C. M., Snaders, B. G. and Kline, K. (1999) Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: Role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 59, 953-961.
22. Yu, W., Liao, Q. Y., Hantash, F. M., Sanders, B. G. and Kline, K. (2001) Activation of extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res. 61, 6569-6576.